Startups channel feed – Endpoints News

Startups channel feed

'Truly different': Roche's former hematology leader shifts a new Versant biotech into gear

4 years ago

RA, Jeito and Omega back a small Swiss biotech to enter an I/O field paved by Adaptimmune

4 years ago

Aurion raises $120M in bid to scale cell therapy for form of blindness

4 years ago

Stanford spinout racks up more support for its mRNA approach to cellular rejuvenation

4 years ago

Backed by billionaire Mike Platt, Engitix scores another deal with Takeda to go after IBD

4 years ago

‘Don’t want to fuss with this stuff’: Another DNA synthesis startup reels in funding

4 years ago

Exclusive: Flagship snags another CEO-partner, on a personal mission, to lead its tRNA boat

4 years ago

Flagship-backed microbiome company Kaleido Biosciences shuts down

4 years ago

Pharma vets with Genentech connection band together to launch new immunotherapy startup, though details are scant

4 years ago

Facing empty reserves by year's end, Lyra is raising nearly double its 2020 IPO as it enters PhIII

4 years ago

Harpoon's fall continues as CMO departs weeks after lead program axed

4 years ago

RA, Atlas-backed biotech spins up with $110M in pursuit of protein degradation via molecular glues

4 years ago

With an eye to 'non-obvious binding sites,' CBC Group launches precision medicine play with $67M and ex-Editas exec at the helm

4 years ago

A new anti-aging biotech wants to add 10 years to your life. But who's funding it?

4 years ago

As part of broader gene therapy ambitions, Takeda links up again with a small Chicago biotech

4 years ago

Scoop: One of Phil Krause’s post-FDA gigs, a biotech trying to develop a Shingrix competitor, goes up for sale

4 years ago

Chirps, chats and Clubhouses: First-time biotech founders turn to social media for advice, investors and recruitment

4 years ago

Scoop: A Penn Parkinson's spinout goes dark as ex-FDA commish Hahn jumps off board

4 years ago

Mukherjee and Vale's Myeloid teams up with David Liu's Prime Medicine in race against Tessera

4 years ago

Cosela maker's early employees aim to replicate 'blueprint' at a new biotech — with an old G1 asset

4 years ago

Celsius aims to cool down inflammation with new investors and more pharma deals

4 years ago

Greg Verdine will have many new C-suite friends at fungus biotech LifeMine after GSK-fueled $175M round

4 years ago

In aiming to bypass CRISPR's delivery issues, one startup eyes the gene editing Spotlight

4 years ago

In year 3 of the pandemic, a new Covid-19 biotech takes flight with an antibody combo and Takeda's ex-vaccines chief at the helm

4 years ago

First page Previous page 41 42 434445 46 47 Next page Last page